Form 8-K - Current report:
SEC Accession No. 0001437749-23-018015
Filing Date
2023-06-21
Accepted
2023-06-21 17:23:34
Documents
17
Period of Report
2023-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230621_8k.htm   iXBRL 8-K 34190
2 EXHIBIT 5.1 ex_536556.htm EX-5.1 12822
3 EXHIBIT 99.1 ex_536281.htm EX-99.1 138452
8 ws01.jpg GRAPHIC 3922
9 ws03.jpg GRAPHIC 2966
  Complete submission text file 0001437749-23-018015.txt   380564

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230621.xsd EX-101.SCH 3873
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230621_def.xml EX-101.DEF 13416
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230621_lab.xml EX-101.LAB 17616
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230621_pre.xml EX-101.PRE 13393
11 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230621_8k_htm.xml XML 4323
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231030896
SIC: 2836 Biological Products, (No Diagnostic Substances)